<DOC>
	<DOCNO>NCT01508949</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate effect NNC 90-1170 ( liraglutide ) weight appetite obese subject type 2 diabetes treat diet and/or sulphonylurea repaglinide .</brief_summary>
	<brief_title>Effect Liraglutide Weight Appetite Obese Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes mellitus Diet treat and/or subject monotherapy sulphonylurea repaglinide HbA1c diet treat subject 6.512 % , inclusive HbA1c sulphonylurea repaglinide treat subject maximum 10 % Body mass index ( BMI ) least 27 kg/m^2 Euthyroid subject Fasting blood glucose 714 mmol/l Impaired liver function Impaired renal function Cardiac problem Uncontrolled treated/untreated hypertension Recurrent severe hypoglycaemia judged Investigator Known suspect allergy trial product relate product Use drug ( except OHAs ( oral hypoglycaemic agent ) , Investigator 's opinion could interfere glucose level body weight . Stable dos , 3 month great , thyroid hormone replacement allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>